Skip to main content
  • Home
  • MF Resrach
  • ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option

ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 08-11-2021
Asset Class:
Benchmark: NIFTY Healthcare TRI.
Expense Ratio: 2.35% As on (31-03-2025)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 214 Cr As on (31-03-2025)
Turn over: 57
NAV (₹): 15.7565 ₹ -0.44 ( -2.7646%)
as on 25-04-2025
CAGR Since Inception - 14.03%
NIFTY Healthcare TRI. - 15.08%

Fund Managers

Dhimant Shah, Rohan Korde, Rajesh Bhatia


Investment Objective

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

PERFORMANCE of ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option

Scheme Performance (%) Data as on - 25-04-2025

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option 16.06 18.95 - - 14.03
NIFTY Healthcare TRI 20.95 19.18 21.04 8.84 15.08
Equity: Sectoral-Pharma and Healthcare 17.88 20.05 22.02 12.44 16.74

RETURNS CALCULATOR for ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Key Performance and Risk Statistics of ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION

Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
ITI Pharma and Healthcare Fund Reg IDCW 08-11-2021 16.06 30.88 18.95 0.0 0.0
HDFC Pharma and Healthcare Fund Gr 04-10-2023 28.13 0.0 0.0 0.0 0.0
WhiteOak Capital Pharma and Healthcare Fund Reg Gr 06-02-2024 26.95 0.0 0.0 0.0 0.0
SBI HEALTHCARE Opportunities Reg Gr 14-07-1999 23.49 37.87 23.75 24.92 12.2
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum 25-07-2018 20.97 38.66 24.26 24.87 0.0
UTI Healthcare Reg Gr 05-08-2005 20.02 34.43 20.19 21.59 11.09
DSP Healthcare Reg Gr 05-11-2018 18.02 32.98 20.16 24.53 0.0
Mirae Asset Healthcare Reg Gr 10-07-2018 16.83 32.15 18.21 22.15 0.0
Tata India Pharma & Healthcare Reg Gr 28-12-2015 16.6 33.61 20.27 21.62 0.0
LIC MF Healthcare Fund Reg Gr 22-02-2019 16.3 30.99 16.26 17.21 0.0

Asset Allocation (%)

PORTFOLIO ANALYSIS of ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option

Portfolio as on

Top 10 Sectors in portfolio (%)

Top 10 Stocks in portfolio (%)